New hookworm vaccine shows promise in early human trial
NCT ID NCT03172975
First seen Dec 29, 2025 · Last updated May 13, 2026 · Updated 29 times
Summary
This study tested a new vaccine to prevent hookworm infection in 39 healthy adults who had never had hookworms. Participants received different versions of the vaccine and were then exposed to hookworms in a controlled setting to see if the vaccine could protect them. The main goals were to check safety and whether the vaccine triggers an immune response.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HOOKWORM INFECTIONS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
George Washington University
Washington D.C., District of Columbia, 20037, United States
Conditions
Explore the condition pages connected to this study.